Limiting Breast Cancer Screening To Women At Higher Levels Of Risk For The Disease Could Improve Cost-Effectiveness, Reduce Overdiagnosis, Research Indicates.

STAT (7/5, Faber) reports a study published in JAMA Oncology “suggests that women might benefit from individualized approaches to mammograms rather than from universal guidelines.” Researchers revealed that, “As fewer women were screened, both the number of overdiagnosed breast cancer decreased, as did the number of breast cancer deaths prevented by screening,” and that the new method “might even be more cost-effective.” Also covering the story are Medscape (7/5, Mulcahy, Subscription Publication), the Radiology Business Journal (7/5, Walter), Aunt Minnie (7/5, Ward).

Print
Author: Nicole Hardy
0 Comments

Categories: NewsNumber of views: 70

Tags: